Topics

Advair Diskus

04:23 EDT 26th August 2019 | BioPortfolio

Advair Diskus, a respiratory medicine produced by GSK, netted $3.6bn in sales in 2009, making it the fourth most successfull drug (in terms of annual sales).  

Advair is used in the treatment of cases of Asthma  resistant to other medications, and cases of COPD, chronic bronchitis and emphysema. It is a bronchodilator, but also has anti-inflammatory actions.

Source; BioPortfolio.com and Advair.com

Add the Advair News Channel to your RSS reader;

Follow the Advair Twitter feed;

Drug maker: GlaxoSmithKline

Indication(s): Asthma and chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

2012 sales: $7.904 billion (£5.046 billion)

Quick Search

review and buy Advair Diskus market research data and corporate reports here